It’s the ‘closest thing to an HIV vaccine’, but who gets access?

A new twice-yearly injection is being hailed as a significant advancement in HIV prevention, potentially revolutionizing how the virus is managed. While the article highlights its potential, it also raises substantial questions regarding access to this new preventative measure. The focus of the discussion is on who will be able to receive this injection, indicating that equitable distribution is a key concern. The article does not specify when this injection will be available or where it will be rolled out. The primary "why" behind the article's focus is the transformative potential of this preventative tool and the subsequent challenges in ensuring widespread availability.